Jackson Thornton Wealth Management LLC Invests $480,000 in STERIS plc $STE

Jackson Thornton Wealth Management LLC acquired a new position in shares of STERIS plc (NYSE:STE) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,980 shares of the medical equipment provider’s stock, valued at approximately $480,000.

A number of other large investors also recently modified their holdings of the business. Root Financial Partners LLC acquired a new position in shares of STERIS during the third quarter worth approximately $39,000. QTR Family Wealth LLC bought a new stake in shares of STERIS during the third quarter valued at about $234,000. Allstate Corp acquired a new stake in STERIS in the third quarter worth about $879,000. NorthCrest Asset Manangement LLC acquired a new position in STERIS during the 3rd quarter valued at about $678,000. Finally, Wealth Enhancement Advisory Services LLC raised its position in shares of STERIS by 106.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 21,668 shares of the medical equipment provider’s stock worth $5,234,000 after buying an additional 11,175 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors.

STERIS Trading Down 0.9%

Shares of NYSE:STE opened at $265.85 on Tuesday. The firm has a fifty day moving average of $259.12 and a two-hundred day moving average of $246.94. The firm has a market capitalization of $26.09 billion, a P/E ratio of 38.20 and a beta of 1.03. The company has a quick ratio of 1.63, a current ratio of 2.37 and a debt-to-equity ratio of 0.27. STERIS plc has a 12-month low of $204.90 and a 12-month high of $269.44.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same period in the previous year, the company earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, equities analysts expect that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Tuesday, November 18th were given a dividend of $0.63 per share. The ex-dividend date of this dividend was Tuesday, November 18th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 0.9%. STERIS’s dividend payout ratio (DPR) is currently 36.21%.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Seven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $273.50.

Insider Activity

In other news, VP Renato Tamaro sold 5,036 shares of the stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the completion of the sale, the vice president owned 5,695 shares of the company’s stock, valued at $1,466,747.25. This represents a 46.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP John Adam Zangerle sold 15,000 shares of the business’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the completion of the sale, the vice president directly owned 33,669 shares in the company, valued at $8,926,998.66. This represents a 30.82% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 25,044 shares of company stock worth $6,586,218 in the last 90 days. Corporate insiders own 1.07% of the company’s stock.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.